Emergency Medicine Continuing Medical Education
Be part of the knowledge.™Episodes 46-60 of 67
Preventative Management of Sickle Cell Disease Complications
MinuteCE®Preventative Management of Sickle Cell Disease Complications
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Emergency Medicine Module
CME/CEUnderstanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Emergency Medicine Module
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Closing Module
CME/CEUnderstanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Closing Module
Repletion Management for Vitamin K Antagonist Anticoagulation
MinuteCE®Repletion Management for Vitamin K Antagonist Anticoagulation
Case Presentation: Management of ICH in the Anticoagulated Patient Using Specific Reversal Therapy: Importance of Timing
MinuteCE®Case Presentation: Management of ICH in the Anticoagulated Patient Using Specific Reversal Therapy: Importance of Timing
Development of a Care Pathway Using Specific Reversal Agents for Anticoagulated Patients With ICH
MinuteCE®Development of a Care Pathway Using Specific Reversal Agents for Anticoagulated Patients With ICH
Reversal of Factor Xa Inhibitor ICH: ANNEXA-4, ANNEXA-I and Real-World Evidence
MinuteCE®Reversal of Factor Xa Inhibitor ICH: ANNEXA-4, ANNEXA-I and Real-World Evidence
Case Presentation: Management of a Patient With Vitamin K Antagonist-Associated Intracranial Hemorrhage (ICH)
MinuteCE®Case Presentation: Management of a Patient With Vitamin K Antagonist-Associated Intracranial Hemorrhage (ICH)
Case Presentation: Management of a Patient With Factor Xa-Associated ICH Using Specific Reversal Therapy
MinuteCE®Case Presentation: Management of a Patient With Factor Xa-Associated ICH Using Specific Reversal Therapy
Reinforcement of Principles, Overcoming Treatment Barriers, and Improving Time to Treatment for ICH
MinuteCE®Reinforcement of Principles, Overcoming Treatment Barriers, and Improving Time to Treatment for ICH
Specific Reversal Therapy for Factor Xa and Factor IIa Inhibitor-Associated ICH Life-Threatening Bleeding
MinuteCE®Specific Reversal Therapy for Factor Xa and Factor IIa Inhibitor-Associated ICH Life-Threatening Bleeding
Repletion or Reversal? Optimizing Specific Therapy for Direct Oral Anticoagulant (DOAC)-Related Life-Threatening Bleeding Using Real-World Experience
MinuteCE®Repletion or Reversal? Optimizing Specific Therapy for Direct Oral Anticoagulant (DOAC)-Related Life-Threatening Bleeding Using Real-World Experience
The Young and the Restless: Meet Crysten Hester
MinuteCE®The Young and the Restless: Meet Crysten Hester
